


Point.1

Healthcare professionals (HCPs) feel pharma don’t understand their pain. Or their passions. The truth is, we’ve lost sight of what’s important. The human behind the HCP.
62% of pharma brands miss their first-year forecasts1, 46% due to poor customer understanding2. We need to turn this around, by getting a clearer picture of HCPs, instead of relying on vague insights and fuzzy data.
Point.1 has one mission: Understand the human behind the HCP with data that actually matters.


Things need to change.
Current data is being used in outdated ways.
We do it differently, utilising the power of over 30 million data points, across 10 therapy areas and geographies. It’s what makes us stand out.
As part of Havas Converged, our range of data covers so much more than prescribing behaviour. Helping us understand who HCPs really are – their personality, lifestyle, emotions, learning styles, influences, and so much more.
From upstream customer segmentation and targeting to downstream media strategy, we’re the only ones with a true end-to-end data set. Giving insights that cut through. Making everything clearer and more connected.

Being more open, opens more doors
With an open-minded approach, we’re able to integrate with YouGov and IQVIA – to find comparisons between the general population and CRM data.
This perspective helps us see things as they really are – from global to local level publication data. And using AI gives us the ability to create a data model that’s quicker and more agile than anything else on the market. Leading to more valuable, actionable HCP insights.
Three essential new products
Point.1 is ahead of the curve in healthcare comms.
These three products prove that. See for yourself.
-
Find out more
Genome goes beyond serving up numbers and helps to make analysis actionable. Allowing you to ensure your communications are relevant and delivered in the right place, at the right time.
-
Find out more
One amazing digital tool combining generative AI with Point.1 data sets. Allowing you to interrogate a virtual HCP that responds with real data truths and actionable insights in seconds, not months.
-
Find out more
Synthesis enables you to create plans for the perfect channel mix without the guesswork. Delivering optimal reach and frequency at each stage - avoiding wastage, maximising local uptake and ROI across your marketing mixes.
Explore our white papers powered by Point.1 data
Every year we invest our expertise into researching an emergent trend, development, or unmet need in healthcare. We do this as a call to arms in the industry, to create a community of like-minded individuals to collaborate with us to drive better healthcare for patients, carers and healthcare professionals alike.

For more information about Point.1, get in touch at europe@havaslynx.com
References
- Trinity Life Sciences. Empowering the Next-Generation Launch Model 2022. Available at: https://trinitylifesciences.com/white-paper/empowering-the-next-generation-launch-model/
- Deloitte. Key factors to improve drug launches. Available at: https://www2.deloitte.com/us/en/insights/industry/life-sciences/successful-drug-launch-strategy.html. Accessed April 2025.
- Transactions of the American Clinical and Climatological association. Challenges and Opportunities facing medical education. 2011. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC3116346/pdf/tacca122000048.pdf
- Havas Lynx. Point. 1 proprietary data. 2024.
- Havas Lynx. Point. 1 proprietary data. 2023.